Bellicum Pharmaceuticals Inc Net Income per Employee (BLCM), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Bellicum Pharmaceuticals Inc   (BLCM)
 

Bellicum Pharmaceuticals Inc Net Income per Employee

BLCM's Quarterly Results, Trends, Rankings, Statistics
Bellicum Pharmaceuticals Inc 's Income per employee grew in the third quarter 2023 on a trailing twelve month basis to $ 36,014, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 56 other companies achieving higher income per employee. While Bellicum Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1509.


What is Income per Employee Ratio?






BLCM Net Income per Employee (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Net Income Change - - - 525.8 % -
Net Income per Employee (TTM) $ 36,014 -53,569 -7,028 -28 -219,111
BLCM's Total Ranking # 1509 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


BLCM Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 57
Healthcare Sector # 114
Overall Market # 1509

Net Income per Employee Statistics
High Average Low
$ 252,250 $ -743,825 $ -1,562,181
(Sep 30 2021)   (Dec 31 2019)







Companies with similar Income per Employee for 12 month ending Sep 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2023Number of Employees Sep 30 2023
Merck and Co Inc   61,520.00 $ 4,614.000  Million 75,000 
Viatris Inc   61,050.00 $ 1,831.500  Million 30,000 
Progyny Inc   60,718.46 $ 51.975  Million 856 
Enzo Biochem Inc  60,615.96 $ 24.307  Million 401 
Organon and Co   58,500.00 $ 585.000  Million 10,000 
Biocorrx Inc   52,117.11 $ 0.938  Million 18 
Schrodinger Inc   51,978.82 $ 44.182  Million 850 
West Pharmaceutical Services Inc   51,796.30 $ 559.400  Million 10,800 
Eton Pharmaceuticals Inc   50,727.27 $ 2.232  Million 44 
Repligen Corp  50,387.50 $ 100.775  Million 2,000 
Mettler toledo International Inc   47,735.54 $ 792.410  Million 16,600 
Gyre Therapeutics Inc   47,176.38 $ 29.155  Million 618 
Protalix Biotherapeutics inc   46,973.45 $ 10.616  Million 226 
Stryker Corp  46,160.71 $ 2,585.000  Million 56,000 
Biomarin Pharmaceutical Inc  45,644.52 $ 147.021  Million 3,221 
Zynex inc   45,625.71 $ 15.969  Million 350 
Abbott Laboratories  44,886.96 $ 5,162.000  Million 115,000 
Medpace Holdings Inc   44,061.61 $ 273.182  Million 6,200 
Medtronic Plc  43,431.58 $ 4,126.000  Million 95,000 
Haemonetics Corporation  42,433.68 $ 128.277  Million 3,023 
Vaso Corporation  42,368.79 $ 11.948  Million 282 
Lemaitre Vascular Inc   41,629.01 $ 27.267  Million 655 
Masimo Corp  40,229.55 $ 88.505  Million 2,200 
Supernus Pharmaceuticals inc   39,297.55 $ 25.622  Million 652 
Embecta Corp   38,054.05 $ 70.400  Million 1,850 
Cv Sciences Inc   37,681.82 $ 1.658  Million 44 
Revvity Inc  36,475.45 $ 401.230  Million 11,000 
Bellicum Pharmaceuticals Inc   36,013.89 $ 2.593  Million 72 
Dexcom Inc   33,963.96 $ 377.000  Million 11,100 
Cryo cell International Inc   32,975.93 $ 2.506  Million 76 


Date modified: 2026-08-29T17:21:50+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.